It has been reported to target Bcl-2 family members including Bcl−2, Bcl−xl, and Bcl−w, promoting the apoptosis of senescent cells [which depend upon anti−apoptotic defenses similarly to cancer cells (Zhu et al., 2015)]. This evidence concerns the gene BCL2 and cancer.